Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data

被引:22
作者
Dreassi, Elena [1 ]
Zizzari, Alessandra Tania [1 ]
Falchi, Federico [1 ]
Schenone, Silvia [2 ]
Santucci, Annalisa [3 ]
Maga, Giovanni [4 ]
Botta, Maurizio [1 ]
机构
[1] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy
[2] Univ Genoa, Dipartimento Sci Farmaceut, I-16132 Genoa, Italy
[3] Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy
[4] IGM CNR, I-27100 Pavia, Italy
关键词
PAMPA; Tyrosine kinase inhibitor; Physico-chemical property; Src; Abl; ARTIFICIAL MEMBRANE-PERMEABILITY; DRUG ABSORPTION; PERMEATION ASSAY; IN-VITRO; PREDICTION; CACO-2; PAMPA; MODEL; MOLECULES; DESIGN;
D O I
10.1016/j.ejmech.2009.03.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A library of 23 pyrazolo-pyrimidine compounds Src tyrosine kinase (TK) inhibitors, that reduced proliferation of a human osteogenic sarcoma cell line, was taken to investigate lack of correlation between inhibition of cellular viability (CV%) and enzymatic inhibition constants (K-i Src). With the aim of understanding this behaviour, we focused on physico-chemical parameters which characterize partition coefficient and diffusion through membrane. Parallel artificial membrane permeability assay (PAMPA) has been frequently used for the evaluation of in vitro permeability of new chemical entities and, in this paper, a new approach for determining permeability of low soluble compounds was obtained. Goodness 2 and of PAMPA methodology was confirmed by log K-w and computational approaches, by VolSurf, Cerius(2) QikProp software programs. The results suggest that the lipophilicity and passive diffusion across the membranes do not significantly influence the activity of the compounds. This trend can be explained by a different target for some of the compounds in our set. In fact some compounds resulted also to be active toward Abl enzyme, another cytoplasmatic TK. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:3712 / 3717
页数:6
相关论文
共 36 条
[1]  
*ACC INC, 2003, CERIUS2 VERS 4 8
[2]  
[Anonymous], 2008, QIKPROP VERS 3 1
[3]   Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA pKaflux method [J].
Avdeef, A ;
Artursson, P ;
Neuhoff, S ;
Lazorova, L ;
Gråsjö, J ;
Tavelin, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (04) :333-349
[4]   PAMPA - Critical factors for better predictions of absorption [J].
Avdeef, Alex ;
Bendels, Stefanie ;
Di, Li ;
Faller, Bernard ;
Kansy, Manfred ;
Sugano, Kiyohiko ;
Yamauchi, Yukinori .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (11) :2893-2909
[5]   Investigation of lipophilicity of anticancer-active thioquinoline derivatives [J].
Bajda, Marek ;
Boryczka, Stanislaw ;
Wietrzyk, Joanna ;
Malawska, Barbara .
BIOMEDICAL CHROMATOGRAPHY, 2007, 21 (02) :123-131
[6]   PAMPA -: a drug absorption in vitro model 7.: Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones [J].
Bermejo, M ;
Avdeef, A ;
Ruiz, A ;
Nalda, R ;
Ruell, JA ;
Tsinman, O ;
González, I ;
Fernández, C ;
Sánchez, G ;
Garrigues, TM ;
Merino, V .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (04) :429-441
[7]   Development and evaluation of an in vitro method for prediction of human drug absorption - II. Demonstration of the method suitability [J].
Corti, G ;
Maestrelli, F ;
Cirri, M ;
Zerrouk, N ;
Mura, P .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (04) :354-362
[8]   Predicting blood-brain barrier permeation from three-dimensional molecular structure [J].
Crivori, P ;
Cruciani, G ;
Carrupt, PA ;
Testa, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (11) :2204-2216
[9]   Molecular lipophilicity in protein modeling and drug design [J].
Efremov, Roman G. ;
Chugunov, Anton O. ;
Pyrkov, Timothy V. ;
Priestle, John P. ;
Arseniev, Alexander S. ;
Jacoby, Edgar .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (04) :393-415
[10]   Permeation of permanently positive charged molecules through artificial membranes - Influence of physico-chemical properties [J].
Fischer, Holger ;
Kansy, Manfred ;
Avdeef, Alex ;
Senner, Frank .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 31 (01) :32-42